Picture of Intocell logo

287840 Intocell Balance Sheet

0.000.00%
kr flag iconLast trade - 00:00
HealthcareHighly SpeculativeSmall CapSucker Stock

Annual balance sheet for Intocell, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

2023
December 31st
2024
December 31st
Period Length:
Source:PROSPECTUSPROSPECTUS
Standards:
IFRS
IFRS
Status:FinalFinal
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments11,0136,958
Net Total Accounts Receivable
Net Total Receivables2021,265
Prepaid Expenses
Total Other Current Assets
Total Current Assets17,40313,495
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment3,5963,343
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets25,94323,711
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities10,70213,508
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Funded Status
Total Liabilities12,71616,190
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity13,2277,521
Total Liabilities & Shareholders' Equity25,94323,711
Total Common Shares Outstanding
0